socalTECH

JANUARY 14, 2021

Simi Valley-based unmanned aerial vehicle maker Aerovironment says it is acquiring Arcturus UAV, a developer of unmanned aircraft used by the military, in a deal worth $405M in cash and stock. AeroVironment said it would pay $355M in cash and $50M in stock for Arcturus, which is based in Petaluma, Claifornia.

Arcturus 113

Arcturus Help Develop Development 113

socalTECH

AUGUST 10, 2012

The use of human milk helps avoid serious side effects that can occur with premature infants if they use cow-based milk. Prolacta is venture backed by such companies as Health Evolution Partners, Alta Partners, DFJ Frontier, Arcturus Capital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates.

Arcturus 164

Arcturus Monrovia Draper Organization 164

socalTECH

SEPTEMBER 23, 2011

Prolacta has been developing processes which process human milk, and convert that into human milk fortifier which helps prevent medical issues often encountered by feeding premature babies with cow-based fortifiers. According to Prolacta, the National Milk Bank will recruit potential breast milk donors for Prolacta. READ MORE>>.

Arcturus 166

Arcturus Draper Monrovia Capital 166

socalTECH

JUNE 15, 2010

The firm, which collects excess milk from mothers for developing its milk fortifiers for premature infants, said it will donate one dollar to Komen per ounce of qualified breast milk it collects through the Helping Hands Milk Bank. The firm said it will commit a minimum amount of $25,000 annually to fund programs at Komen.

Arcturus 221

Arcturus Draper Monrovia Funding 221

socalTECH

SEPTEMBER 3, 2010

Santa Monica-based TrueCar.com , the online automotive pricing startup headed up by Scott Painter, said Thursday that it has launched a new tool to help new car buyers. The firm is venture backed by Anthem Ventures, Arcturus Capital, Capital One, Capricorn Management, and GRP Partners.

Truecar 154

Truecar Pricing Tool Arcturus 154

socalTECH

DECEMBER 1, 2010

Prolacta is venture backed by Alta Partners, DFJ Frontier, Arcturus Capital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates L.P. READ MORE>>.

Arcturus 124

Arcturus Draper Monrovia Screening 124

Xconomy

FEBRUARY 9, 2018

Second, it still hasn’t proven whether the combination helps patients more than its immunotherapy drug nivolumab (Opdivo) used alone. But the results, touted as positive, left more questions than answers. First, Bristol changed the trial’s structure midstream. More results are still to come.

Help 58

Help Develop Development Arcturus 58